 The systematic review and meta-analysis found that patients with diabetes have an increased risk of failure and death during tuberculosis treatment. The risk ratio R for the combined outcome of failure and death is 1.69, while the R of death is 1.89. Diabetes also increases the risk of relapse. However, there was no evidence for an increased risk of tuberculosis recurrence with drug-resistant strains among people with diabetes. The studies assessing sputum culture conversion after two to three months of tuberculosis therapy were heterogeneous. The findings highlight the need for increased attention to treatment of tuberculosis in people with diabetes, which may include testing for suspected diabetes, improved glucose control, and increased clinical and therapeutic monitoring. This article was authored by Hart Jessica E, John Christie Y, Harry's Anthony D, and others. We are article.tv, links in the description below.